Linepharma International Inc. is a privately held pharmaceutical company specializing in the licensing, regulatory, marketing, sales, and distribution of niche pharmaceutical products with a primary focus on sexual and reproductive health.

Formerly Celopharma Inc., Linepharma International Inc. is the Canadian sales and distribution arm of Linepharma International Ltd., the first pharmaceutical company to commercialize the co-packaged presentation of the two products required to complete a medication abortion. Known as Mifegymiso in Canada, our product for medication abortion is distributed across the country through pharmacy, clinics, and hospitals.

Linepharma is passionately committed to maintaining and expanding Canadian’s access and rights to sexual and reproductive health products and services.